3,4,5-Trihydroxycinnamic acid increases heme-oxygenase-1 (HO-1) and decreases macrophage infiltration in LPS-induced septic kidney

Molecular and Cellular Biochemistry

Volumn 397, Issue 1-2, 2014, Pages 109-116

  Lee, Jae Won ^a   Kwon, Jae Hyun ^a   Lim, Man Sup ^a   Lee, Hee Jae ^a   Kim, Sung Soo ^a   Lim, So Young ^b   Chun, Wanjoo ^a  

^a Kangwon National University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

Author keywords

3,4,5 Trihydroxycinnamic acid; Heme oxygenase 1; Kidney; Lipopolysaccharide; Sepsis

Indexed keywords

3,4,5, TRIHYDROXYCINNAMIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; COUMARIC ACID; CYCLOOXYGENASE 2; HEME OXYGENASE 1; I KAPPA B ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URINARY TRACT AGENT; CINNAMIC ACID; CINNAMIC ACID DERIVATIVE; HMOX1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PTGS2 PROTEIN, MOUSE; PTGS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ESCHERICHIA COLI; EXPERIMENTAL NEPHRITIS; MACROPHAGE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SEPSIS; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; SEPTIC SHOCK;

ANIMALS; CELL LINE; CINNAMATES; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MESANGIAL CELLS; MICE; MICE, INBRED BALB C; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SHOCK, SEPTIC;

EID: 84911997771     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2177-1     Document Type: Article

References (33)

1. Kang JS, Jeon YJ, Park SK, Yang KH, Kim HM (2004) Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol 67(1):175–181
2. Rietschel ET, Brade H (1992) Bacterial endotoxins. Sci Am 267(2):54–61
3. Chen YC, Chen CH, Ko WS, Cheng CY, Sue YM, Chen TH (2011) Dipyridamole inhibits lipopolysaccharide-induced cyclooxygenase-2 and monocyte chemoattractant protein-1 via heme oxygenase-1-mediated reactive oxygen species reduction in rat mesangial cells. Eur J Pharmacol 650(1):445–450
4. Juman S, Yasui N, Ikeda K, Ueda A, Sakanaka M, Negishi H, Miki T (2012) Caffeic acid phenethyl ester suppresses the production of pro-inflammatory cytokines in hypertrophic adipocytes through lipopolysaccharide-stimulated macrophages. Biol Pharm Bull 35(11):1941–1946
5. Hsing CH, Chou W, Wang JJ, Chen HW, Yeh CH (2011) Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury. Nephrol Dial Transplant 26(4):1162–1172
6. Lee JW, Bae CJ, Choi YJ, Kim SI, Kwon YS, Lee HJ, Kim SS, Chun W (2014) 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation in vitro and improves survival of mice in LPS-induced endotoxemia model in vivo. Mol Cell Biochem 390(1–2):143–153
7. Zhong Y, Liu T, Lai W, Tan Y, Tian D, Guo Z (2013) Heme oxygenase-1-mediated reactive oxygen species reduction is involved in the inhibitory effect of curcumin on lipopolysaccharide-induced monocyte chemoattractant protein-1 production in RAW264.7 macrophages. Mol Med Rep 7(1):242–246
8. Chakraborty P, Saraswat G, Kabir SN (2014) alpha-Dihydroxychalcone-glycoside (alpha-DHC) isolated from the heartwood of Pterocarpus marsupium inhibits LPS induced MAPK activation and up regulates HO-1 expression in murine RAW 264.7 macrophage. Toxicol Appl Pharmacol 277(1):95–107
9. Lee HJ, Lim HJ, da Lee Y, Jung H, Kim MR, Moon DC, Kim KI, Lee MS, Ryu JH (2010) Carabrol suppresses LPS-induced nitric oxide synthase expression by inactivation of p38 and JNK via inhibition of I-kappaBalpha degradation in RAW 264.7 cells. Biochem Biophys Res Commun 391(3):1400–1404
10. Park SY, Seetharaman R, Ko MJ, Kim DY, Kim TH, Yoon MK, Kwak JH, Lee SJ, Bae YS, Choi YW (2014) Ethyl linoleate from garlic attenuates lipopolysaccharide-induced pro-inflammatory cytokine production by inducing heme oxygenase-1 in RAW264.7 cells. Int Immunopharmacol 19(2):253–261
11. Lee IS, Lim J, Gal J, Kang JC, Kim HJ, Kang BY, Choi HJ (2011) Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells. Neurochem Int 58(2):153–160
12. Huang J, Qin Y, Liu B, Li GY, Ouyang L, Wang JH (2013) In silico analysis and experimental validation of molecular mechanisms of salvianolic acid A-inhibited LPS-stimulated inflammation, in RAW264.7 macrophages. Cell Prolif 46(5):595–605
13. Tsoyi K, Lee TY, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC (2009) Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo. Mol Pharmacol 76(1):173–182
14. Ha YM, Ham SA, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Park MK, Chang KC (2011) beta(1)-adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice. Biochem Pharmacol 82(7):769–777
15. Rabe C, Steenkamp JA, Joubert E, Burger JF, Ferreira D (1994) Phenolic metabolites from rooibos tea. Phytochemistry 35:1559–1565
16. Kim YC (2010) Neuroprotective phenolics in medicinal plants. Arch Pharm Res 33(10):1611–1632
17. Lee JW, Cheong IY, Kim HS, Lee JJ, Lee YS, Kwon YS, Kim MJ, Lee HJ, Kim SS, Chun W (2011) Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial Cells. Korean J Physiol Pharmacol 15(1):9–15
18. Nagasaka R, Chotimarkorn C, Shafiqul IM, Hori M, Ozaki H, Ushio H (2007) Anti-inflammatory effects of hydroxycinnamic acid derivatives. Biochem Biophys Res Commun 358(2):615–619
19. Byun JS, Lee JW, Kim SY, Kwon KJ, Sohn JH, Lee K, Oh D, Kim SS, Chun W, Lee HJ (2010) Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice. Peptides 31(11):2094–2099
20. Li QF, Zhu YS, Jiang H, Xu H, Sun Y (2009) Heme oxygenase-1 mediates the anti-inflammatory effect of isoflurane preconditioning in LPS-stimulated macrophages. Acta Pharmacol Sin 30(2):228–234
21. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN (2008) Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 76(8):967–973
22. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405–455
23. Kuprash DV, Udalova IA, Turetskaya RL, Rice NR, Nedospasov SA (1995) Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene 11(1):97–106
24. Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, Lee JD, Choi YH, Kim GY (2007) Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7(8):1092–1101
25. Zheng LT, Ock J, Kwon BM, Suk K (2008) Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8(3):484–494
26. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351(2):159–169
27. Almeida WS, Maciel TT, Di Marco GS, Casarini DE, Campos AH, Schor N (2006) Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells. Kidney Int 69(6):974–980
28. Camussi G, Ronco C, Montrucchio G, Piccoli G (1998) Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 66:S38–S42
29. Yan W, Zhao K, Jiang Y, Huang Q, Wang J, Kan W, Wang S (2002) Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide. Shock 17(5):433–438
30. Camussi G, Mariano F, Biancone L, De Martino A, Bussolati B, Montrucchio G, Tobias PS (1995) Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 155(1):316–324
31. Rehman MU, Yoshihisa Y, Miyamoto Y, Shimizu T (2012) The anti-inflammatory effects of platinum nanoparticles on the lipopolysaccharide-induced inflammatory response in RAW 264.7 macrophages. Inflamm Res 61(11):1177–1185
32. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK (2006) Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 290(6):F1453–F1462
33. Lee Y, Shin DH, Kim JH, Hong S, Choi D, Kim YJ, Kwak MK, Jung Y (2010) Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur J Pharmacol 643(1):21–28